Regulatory Approval - Novo Nordisk's Wegovy received FDA approval to treat a serious liver disease [1] Pharmaceutical Industry - Wegovy is described as a blockbuster weight-loss drug [1]

Novo shares advanced after the drugmaker’s blockbuster weight-loss drug Wegovy received US approval to treat a serious form of liver disease https://t.co/Fi1V1nX2Rn ...

Regulatory Approval - Novo Nordisk's Wegovy received FDA approval for treating a serious liver disease [1]

Market Opportunity - Dr Reddy's Laboratories is preparing to launch a generic version of semaglutide, the active ingredient in Novo Nordisk's Wegovy, next year [1] Pharmaceutical Industry - The generic version targets the weight-loss drug market [1]

Pharmaceutical Industry - China's homemade weight-loss drug mazdutide has been approved [1] - Doctors hope mazdutide will help more patients get treatment [1]